Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Capital Employed (2016 - 2025)

Adma Biologics' Return on Capital Employed history spans 13 years, with the latest figure at 0.36% for Q4 2025.

  • For Q4 2025, Return on Capital Employed changed 0.0% year-over-year to 0.36%; the TTM value through Dec 2025 reached 0.36%, changed 0.0%, while the annual FY2025 figure was 0.39%, 0.0% changed from the prior year.
  • Return on Capital Employed reached 0.36% in Q4 2025 per ADMA's latest filing, up from 0.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.36% in Q4 2025 to a low of 0.32% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.03%, with a median of 0.03% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: dropped -3bps in 2021, then surged 33bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then surged by 46bps to 0.14% in 2022, then surged by 154bps to 0.07% in 2023, then surged by 384bps to 0.36% in 2024, then grew by 0bps to 0.36% in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Return on Capital Employed are 0.36% (Q4 2025), 0.33% (Q3 2025), and 0.34% (Q2 2025).